Related News
Pharmacogenomics Symposium Showcased Progress and Potential in the Field
Tuesday, April 23, 2024
9th Annual Research Conference Highlights Innovation and Discoveries from Across the Valley
Thursday, April 18, 2024
Nanoparticle Delivery of FZD4 to Lung Endothelial Cells Inhibits Lung Cancer Progression and Metastases
Monday, April 08, 2024AZ Big Media
The University of Arizona and other public universities statewide are partnering on research into Valley fever. John Galgiani, MD, director of the Valley Fever Center for Excellence at the University of Arizona and associate clinical professor of Internal Medicine with the College of Medicine – Phoenix, is leading the team focusing on singling out where the hotspots are by researching genetic clusters.
By learning more about the specific areas where the fungus is coming from, more cases can be prevented. Dr. Galgiani confirms a vaccine is being developed at the University of Arizona to prevent Valley fever in dogs, which will be a precursor for a human vaccine. Testing has already been successful, and the veterinary Valley fever vaccine is scheduled to go live in 2024.
About the College
Founded in 2007, the University of Arizona College of Medicine – Phoenix inspires and trains exemplary physicians, scientists and leaders to optimize health and health care in Arizona and beyond. By cultivating collaborative research locally and globally, the college accelerates discovery in a number of critical areas — including cancer, stroke, traumatic brain injury and cardiovascular disease. Championed as a student-centric campus, the college has graduated more than 800 physicians, all of whom received exceptional training from nine clinical partners and more than 2,700 diverse faculty members. As the anchor to the Phoenix Bioscience Core, which is projected to have an economic impact of $3.1 billion by 2025, the college prides itself on engaging with the community, fostering education, inclusion, access and advocacy.